Akoya Biosciences Inc (AKYA)

2.39 -0.07 (-2.85%) USD  |  NASDAQ  |  Dec 27, 16:00
2.40 +0.01 (+0.42%) After-Hours: 20:00
More

Akoya Biosciences Research and Development Expense (Quarterly): 4.474M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for AKYA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Bruker Corp 98.10M
Azenta Inc 8.412M
Harvard Bioscience Inc 2.567M
Bionano Genomics Inc 4.717M
Singular Genomics Systems Inc 9.568M